Francesco De Rubertis insider trades

Open-market stock purchases and sales by Francesco De Rubertis, Director at Centessa Pharmaceuticals plc, from SEC Form 4 filings since Mar 20, 2014.

Track record: 86% of 14 scored buys are up 5% or more since purchase, averaging +174%.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—

Companies traded

  • CNTA Centessa Pharmaceuticals plc: 12 buys, last Jun 24, 2026
  • NERV Minerva Neurosciences, Inc: 3 buys, 1 sale, last Dec 12, 2016
  • VSAR Versartis, Inc: other filings, last Mar 20, 2014

Get free alerts when Francesco De Rubertis files a new trade →